Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04642690 · ClinicalTrials.gov registry record
Nitrates and IL-8 in Barrett's Esophagus
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 9
- Enrollment target
NCT04642690: Clinical Trial study, sponsored by Mayo Clinic.
NCT04642690 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04642690 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 9 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if nitrates and IL-8 (which are found in food and throughout the body regulating stomach acidity) play a role in Barrett's Esophagus and/or Esophageal Adenocarcinoma severity and if screening for these biomarkers can help predict patients that are more at risk for developing worsening disease.
Primary Outcome
Nitrate levels in serum, saliva and tissue in patients with normal squamous epithelium, erosive esophagitis, non-dysplastic BE (NDBE), and BE with high-grade dysplasia (HGD) or EAC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2020-09-24 |
| Est. Completion | 2022-12-09 |
Why NCT04642690 stopped before completion
NCT04642690 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04642690 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04642690 about?
NCT04642690 is a clinical study titled "Nitrates and IL-8 in Barrett's Esophagus". The purpose of this study is to determine if nitrates and IL-8 (which are found in food and throughout the body regulating stomach acidity) play a role in Barrett's Esophagus and/or Esophageal Adenocarcinoma severity and if screening for these biomarkers can help predict patients that are more at ri...
What is the current status of trial NCT04642690?
This trial is currently terminated. The enrollment target is 9 participants. The study started on 2020-09-24. Estimated completion is 2022-12-09.
Who is sponsoring clinical trial NCT04642690?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI